Crossject | Needle free injection

ZENEO®, a unique device worldwide

https://www.crossject.com/en/zeneor-products

Crossject: the expert in needle-free injection

Dare, persevere and innovate, to save lives simply

http://www/google.fr

Crossject is revolutionizing the administration of well-established treatments with its needle-free auto-injector ZENEO®. The prefilled, single-use device propels the medicine through the skin in less than a tenth of a second. Crossject currently has seven solutions in advanced stages of development, six of which are for emergency situations.

Our news

CPhI

24-26 October 2023 in Barcelona, Spain

HealthTech innovation days

24-25 October in Paris, France

Financial news: Crossject announces initiation of coverage by ODDO BHF

The ODDO BHF analysts rated Crossject as “Outperform” with a price target of €7.10, citing the significant advantages associated with the company’s needle-free ZENEO® device, which enables easily administered injections to be delivered by patients and untrained caregivers in a fraction of a second in emergency situations. Crossject’s contract with the U.S.